Bora (6472) Monthly Revenue

Market: TWSE-listed · Industry: Biotech & Medical · 保瑞

Bora (6472) reported revenue of NT$1.99 billion for Oct 2026, +15.9% year on year and -14.4% from the previous month. Revenue for Jan–Oct 2026 was NT$18.29 billion (+10.1% year on year).

Year-on-year revenue growth: 6 months in a row. →

In Oct 2026, it ranked No. 3 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$2.09 billion24/10Nov 2024 NT$1.68 billionDec 2024 NT$1.99 billionJan 2025 NT$1.64 billionFeb 2025 NT$1.73 billion25/02Mar 2025 NT$1.44 billionApr 2025 NT$2.05 billionMay 2025 NT$1.51 billionJun 2025 NT$1.65 billion25/06Jul 2025 NT$1.8 billionAug 2025 NT$1.37 billionSep 2025 NT$1.72 billionOct 2025 NT$1.72 billion25/10Nov 2025 NT$1.5 billionDec 2025 NT$1.66 billionJan 2026 NT$1.14 billionFeb 2026 NT$1.33 billion26/02Mar 2026 NT$1.53 billionApr 2026 NT$1.48 billionMay 2026 NT$2.11 billionJun 2026 NT$2.3 billion26/06Jul 2026 NT$1.9 billionAug 2026 NT$2.18 billionSep 2026 NT$2.33 billionOct 2026 NT$1.99 billion26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$1.99 billion+15.9%-14.4%
Sep 2026NT$2.33 billion+35.1%+6.4%
Aug 2026NT$2.18 billion+59.2%+14.9%
Jul 2026NT$1.9 billion+5.8%-17.2%
Jun 2026NT$2.3 billion+39.2%+8.7%
May 2026NT$2.11 billion+40.2%+42.5%
Apr 2026NT$1.48 billion-27.5%-2.9%
Mar 2026NT$1.53 billion+6.3%+15.2%
Feb 2026NT$1.33 billion-23.2%+16.1%
Jan 2026NT$1.14 billion-30.2%-31.1%
Dec 2025NT$1.66 billion-16.6%+10.4%
Nov 2025NT$1.5 billion-10.8%-12.6%
Oct 2025NT$1.72 billion-17.8%-0.2%
Sep 2025NT$1.72 billion-15.0%+25.4%
Aug 2025NT$1.37 billion-26.6%-23.7%
Jul 2025NT$1.8 billion+4.5%+8.9%
Jun 2025NT$1.65 billion-2.7%+9.4%
May 2025NT$1.51 billion-10.7%-26.3%
Apr 2025NT$2.05 billion+24.6%+42.3%
Mar 2025NT$1.44 billion+91.0%-16.8%
Feb 2025NT$1.73 billion+96.3%+5.5%
Jan 2025NT$1.64 billion+33.6%-17.6%
Dec 2024NT$1.99 billion+107.9%+18.0%
Nov 2024NT$1.68 billion+49.4%-19.4%
Oct 2024NT$2.09 billion+85.9%+3.2%

Jan–Oct 2026 cumulative: NT$18.29 billion (+10.1% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Bora vs PEC / Bora vs Lotus Pharm / Bora vs Great Tree Pharmacy

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%
GKB1707NT$748.3 million-30.8%

Company remark (original Chinese)

停業單位營收累計為5,152千元

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16